JamesKennethGodfreyMD

PubMed

• 1 citations
  T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses.
  Chen, X., Chen, M., Cooper, A., Tumuluru, S., Yu, J., Venkataraman, G., Smith, S., Brody, J., Godfrey, J., Kline, J.> ;Cancer Immunology Research. 2024 Mar 4
• CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.
  Cooper, A., Tumuluru, S., Kissick, K., Venkataraman, G., Song, J., Lytle, A., Duns, G., Yu, J., Kotlov, N., Bagaev, A., Hodkinson, B., Srinivasan, S., Smith, S., Scott...> ;Journal of Clinical Oncology. 2024 Feb 1
• 7 citations
  Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade.
  Matthew Mei, Lu Chen, James Godfrey, Joo Song, Colt Egelston, Sandrine Puverel, L Elizabeth Budde, Saro Armenian, Liana Nikolaenko, Mary Nwangwu, Weihua Guo, Lei Gao, ...> ;Blood. 2023 Oct 19
• 5 citations
  Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-c...
  Shin Yeu Ong, Stacy Pak, Matthew Mei, Yan Wang, Leslie Popplewell, John H Baird, Alex F Herrera, Geoffrey Shouse, Liana Nikolaenko, Jasmine Zain, James Godfrey, Myo Ht...> ;American Journal of Hematology. 2023 Nov 1
• 5 citations
  Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
  Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Rachel Treitman, Manali K Kamdar, Bradley M Haverkos, James Godfrey, Melissa A Babcook, Timothy J V...> ;Blood Advances. 2023 Aug 22
• Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
  James Godfrey, Matthew Mei, Lu Chen, Joo Y Song, Victoria Bedell, Elizabeth Budde, Saro Armenian, Sandrine Puverel, Liana Nikolaenko, Robert Chen, Shari Daniels, Neena...> ;Haematologica. 2024 Feb 1
• 5 citations
  TIGIT is a key inhibitory checkpoint receptor in lymphoma.
  James Godfrey, Xiufen Chen, Nicole Sunseri, Alan Cooper, Jovian Yu, Arina Varlamova, Dmitry Zarubin, Yuriy Popov, Connor Jacobson, Ekaterina Postovalova, Zhongmin Xian...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• 8 citations
  Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
  James Godfrey, Hongtao Liu, Jovian Yu, Michael Tallarico, Emily Curran, Andrew Artz, Peter A Riedell, Wendy Stock, Theodore Karrison, Carrie Fitzpatrick, Girish Venkat...> ;Blood Advances. 2023 Mar 28
• 3 citations
  Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma.
  Joo Y Song, Mary Nwangwu, Ting-Fang He, Weiwei Zhang, Hany Meawad, Victoria Bedell, Joyce Murata-Collins, Pamela Skrabek, Michel R Nasr, David Scott, James Godfrey, Pe...> ;Haematologica. 2023 Aug 1
• 1 citations
  PD-1 Blockade After Avelumab in Relapsed/Refractory Classical Hodgkin Lymphoma.
  Swetha Kambhampati, Matthew G Mei, James Godfrey, Tanya Siddiqi, Amandeep Salhotra, Robert Chen, Eileen Smith, Leslie L Popplewell, Alex F Herrera> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• 4 citations
  Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
  Jonathan A. Trujillo, James Godfrey, Yifei Hu, Jun Huang, Sonali M. Smith, Matthew J. Frigault, Zachariah DeFilipp, Daniel Appelbaum, Yonglin Pu, Nicholas Feinberg, Th...> ;Blood. 2021 Jun 17
• 17 citations
  Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy
  Nicole A. Carreau, Philippe Armand, Reid W. Merryman, Ranjana H. Advani, Michael A. Spinner, Alex F. Herrera, Radhakrishnan Ramchandren, Muhammad Saad Hamid, Sarit Ass...> ;British Journal of Haematology. 2020 Oct 1
• 24 citations
  Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
  Nicole A. Carreau, Orrin Pail, Philippe Armand, Reid W. Merryman, Ranjana H. Advani, Michael A. Spinner, Alex F. Herrera, Robert T. Chen, Sarah Tomassetti, Radhakrishn...> ;The Oncologist. 2020 Oct 1
• 6 citations
  Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma
  Reid W. Merryman, Nicole A. Carreau, Ranjana H. Advani, Michael A. Spinner, Alex F. Herrera, Robert T. Chen, Sarah Tomassetti, Radhakrishnan Ramchandren, Muhammad Hami...> ;The Oncologist. 2020 Jun 1
• 11 citations
  Diagnostic utility of STAT6 YE361 expression in classical Hodgkin lymphoma and related entities
  Charles Van Slambrouck, Jooryung Huh, Cheolwon Suh, Joo Y. Song, Madhu P. Menon, Aliyah R. Sohani, Amy S. Duffield, Reva C. Goldberg, Paola Dama, Kazuma Kiyotani, Jame...> ;Modern Pathology. 2020 May 1
• 110 citations
  The immune landscape and response to immune checkpoint blockade therapy in lymphoma
  Justin Kline, James Godfrey, Stephen M. Ansell> ;Blood. 2020 Feb 20
• 10 citations
  Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
  James Godfrey, Chadi Nabhan, Theodore Karrison, Justin Kline, Kenneth S. Cohen, Michael R. Bishop, Walter M. Stadler, Reem Karmali, Parameswaran Venugopal, Aaron P. Ra...> ;Cancer. 2019 Jun 1
• 84 citations
  PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype.
  James Godfrey, Sravya Tumuluru, Riyue Bao, Michael J. Leukam, Girish Venkataraman, John Phillip, Carrie Fitzpatrick, James McElherne, Brendan W. MacNabb, Robert Orlows...> ;Blood. 2019 May 23
• 12 citations
  An update in treating transformed lymphoma.
  James Godfrey, Michael J. Leukam, Sonali M. Smith> ;Best Practice & Research. Clinical Haematology. 2018 Sep 1
• 49 citations
  Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
  Sonali M. Smith, James Godfrey, Kwang Woo Ahn, Alyssa DiGilio, Sairah Ahmed, Vaibhav Agrawal, Veronika Bachanova, Ulrike Bacher, Asad Bashey, Javier Bolaños-Meade, Mit...> ;Cancer. 2018 Jun 15
• 87 citations
  Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R
  Lisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, Nancy L. Bartlett, Ann S. LaCasce, William Martin-Doyle, Matthew J. Barth, Kimberly Davies, Kristie A. Blum, Beth A....> ;British Journal of Haematology. 2017 Dec 1
• 71 citations
  Mechanisms of Immune Tolerance in Leukemia and Lymphoma
  Emily Curran, James Godfrey, Justin Kline> ;Trends in Immunology. 2017 Jul 1
• 29 citations
  PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation.
  James Godfrey, Michael R. Bishop, Sahr Syed, Elizabeth Hyjek, Justin Kline> ;Journal for Immunotherapy of Cancer. 2017 Feb 21
• 57 citations
  The role of natural killer cells in immunity against multiple myeloma.
  James Godfrey, Don M. Benson> ;Leukemia & Lymphoma. 2012 Mar 16
• Join now to see all

Abstracts/Posters

• Integrative Immunogenomic Characterization of Diffuse Large B-Cell Lymphoma (DLBCL) Identifies Four Molecular Subtypes with Distinct Immune Landscapes
  James Godfrey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019